Semaglutide biosimilar(Camurus)

N/A

Report date: 2025/03/12 14:46:51

Base Information

Drug NameSemaglutide biosimilar(Camurus)
Drug Alias Name吉优泰CAM2056CAM-2056
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCamurus Ab
China Registration ClassN/A

Develop Information

Active CompaniesCamurus Ab
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A